<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02481648</url>
  </required_header>
  <id_info>
    <org_study_id>EMMPC</org_study_id>
    <nct_id>NCT02481648</nct_id>
  </id_info>
  <brief_title>Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer</brief_title>
  <acronym>EMMPC</acronym>
  <official_title>A Pilot Study to Evaluate Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Newly Diagnosed Prostate Cancer Patients Undergoing Radical Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vancouver Prostate Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vancouver Prostate Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to evaluate the feasibility of a larger clinical trial assessing an
      exercise program during the &quot;teachable moment&quot; in patients with prostate cancer and measuring
      its effect on tumor apoptosis signaling, lipogenesis and steroidogenesis. Participants will
      be randomized between a 4-12 week exercise program or to standard of care only. Participants
      will be assessed at screening, baseline (day 0), throughout the trial intervention (days
      1-84), post-intervention visit (prior to radical prostatectomy) and final study visit
      6-months post-radical prostatectomy. At each assessment, physical, biological samples and
      psychosocial assessments will take place.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 2015</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility: Number of patients screened per month</measure>
    <time_frame>From start of recruitment to end of recruitment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility: Number of patients enrolled per month</measure>
    <time_frame>From start of recruitment to end of recruitment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility: Proportion of screen eligible patients who enroll</measure>
    <time_frame>From start of recruitment to end of recruitment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility: Treatment-specific retention rates</measure>
    <time_frame>From date of randomization to end of treatment intervention for each participant, an average of 4-12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility: Rates of adherence to protocol for the exercise intervention arm and control arm</measure>
    <time_frame>From date of randomization to end of treatment intervention for each participant, an average of 4-12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility: Proportion of planned assessments that are completed respectively</measure>
    <time_frame>From date of randomization to end of study for each participant, an average of 7 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical Fitness: Godin Leisure-Time Exercise questionnaire (GLTEQ) and activity logs</measure>
    <time_frame>Baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery</time_frame>
    <description>Comparison of activity at baseline, during the study and at the end of the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Fitness: Anthropometrics (i.e. BMI &amp; waist circumference)</measure>
    <time_frame>Baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery</time_frame>
    <description>Comparison of baseline versus end of study anthropometrics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Fitness: Aerobic fitness using a submaximal graded exercise test</measure>
    <time_frame>Baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery</time_frame>
    <description>Comparison of baseline versus end of study aerobic fitness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Fitness: Functional fitness using the 30-second chair stand and 30-second arm curl</measure>
    <time_frame>Baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery</time_frame>
    <description>Comparison of baseline versus end of study functional fitness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Fitness: Muscular strength test upper and lower extremity using the 1RM</measure>
    <time_frame>Baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery</time_frame>
    <description>Comparison of baseline versus end of study muscular strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Fitness: Blood pressure and pulse</measure>
    <time_frame>Baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery</time_frame>
    <description>Comparison of baseline versus end of study blood pressure and pulse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biological: Collection of urine, blood, biopsy and RP specimens</measure>
    <time_frame>Baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery</time_frame>
    <description>Ability to collect these samples for each participant will be assessed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial: Functional Assessment of Cancer Therapy-Prostate questionnaire (FACT-P)</measure>
    <time_frame>Baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery</time_frame>
    <description>Comparison of questionnaire scores at baseline versus end of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial: Centre for Epidemiologic Studies Depression scale (CES-D)</measure>
    <time_frame>Baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery</time_frame>
    <description>Comparison of questionnaire scores at baseline versus end of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial: International Prostate Symptom Score (IPSS)</measure>
    <time_frame>Baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery</time_frame>
    <description>Comparison of questionnaire scores at baseline versus end of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychosocial: International Index of Erectile Function scale (IIEF)</measure>
    <time_frame>Baseline (month 0), pre-surgery (4-12 weeks) and 6-months post surgery</time_frame>
    <description>Comparison of questionnaire scores at baseline versus end of study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>ARM1: Exercise Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The exercise program is a 4-12 weeks progressive combined resistance and aerobic exercise for participants from time of diagnosis to RP.
Participants will undergo twice weekly group-training (four-six participants/group) combined aerobic-resistance sessions (1hr per session), supervised by trained exercise therapists. In addition, participants will undergo home-based aerobic exercise independently three times a week with the goal to meet the current physical activity guidelines for cancer survivors (150min/week of moderate intensity aerobic activity and two resistance training sessions per week). Participants will also be supplied with the Canadian Physical Activity and Sedentary Behavior Guidelines Handbook and accompanying Log Sheets.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ARM2: Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will be asked to exercise as they normally would and will be asked to record their exercise activity on provided activity logs.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <arm_group_label>ARM1: Exercise Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Completed Pre-Screening Consent Form

          -  Men with CaP, who are deemed suitable by a urologist for RP

          -  Engaging in &lt;90 minutes/week of moderate-to-vigorous exercise

          -  BMI &lt;40

          -  Age &gt;19

          -  Able to speak and read English (to be able to complete questionnaires)

          -  Willing to comply with all study procedures (including committing to twice-weekly
             visits to the study exercise facility and exercise at home) and be available for the
             duration of the study

          -  Provide signed and dated informed consent form

        Exclusion Criteria:

        â€¢ Men with a medical, musculoskeletal condition or use of mobility aid that prevents
        participation in the exercise intervention.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Black, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Urologic Sciences, University of British Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vancouver Prostate Centre</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2015</study_first_submitted>
  <study_first_submitted_qc>June 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2015</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vancouver Prostate Centre</investigator_affiliation>
    <investigator_full_name>Peter Black, MD</investigator_full_name>
    <investigator_title>Urologic Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
    <mesh_term>Disease Progression</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

